---
schema_version: "secwatch.filing_event.v1"
accession: "0000014272-23-000018"
form_type: "8-K"
ticker: "BMY"
cik: "0000014272"
company_name: "BRISTOL MYERS SQUIBB CO"
filed_at: "2023-02-02T23:59:59+00:00"
generated_at: "2026-06-20T02:10:07.663095+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Bristol Myers Q4 revenue $11.4B, GAAP EPS $0.95; full-year $46.2B, EPS $2.95; in-line/new product portfolio grows 7%

## Summary
- Q4 2022 revenues $11,406M (-5% YoY); full-year $46,159M (flat YoY).
- GAAP EPS: Q4 $0.95, full-year $2.95; Non-GAAP EPS: Q4 $1.82, full-year $7.70.
- In-Line and New Product Portfolio revenues up 7% (12% ex-FX) Q4; full-year up 9% (13% ex-FX).
- Revlimid revenues declined 32% Q4 and 22% full-year due to loss of exclusivity.
- 2023 GAAP and non-GAAP guidance provided reflecting continued revenue and earnings growth.

## SEC filing metadata
- accession: 0000014272-23-000018
- form_type: 8-K
- ticker: BMY
- cik: 0000014272
- company_name: BRISTOL MYERS SQUIBB CO
- filed_at: 2023-02-02T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/14272/000001427223000018/0000014272-23-000018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/14272/000001427223000018/bmy-20230202.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000014272-23-000018
- JSON: https://secwatch.observer/filing/0000014272-23-000018.json
- Plain text: https://secwatch.observer/filing/0000014272-23-000018.txt

## Key facts
- Earnings Releases
  BRISTOL MYERS SQUIBB CO reported the fourth quarter of 2022 results: revenue $11.4 Billion, EPS $0.95.
  - Period: the fourth quarter of 2022
  - Revenue: $11.4 Billion
  - EPS: $0.95
  - Result: reported results
  source text: • Reports Fourth Quarter Revenues of $11.4 Billion; Full-Year Revenues of $46.2 Billion ◦ Fourth Quarter Revenues from In-Line Products and New Product Portfolio were $9.0 Billion, an Increase of 7%, or 12% When Adjusted for Foreign Exchange ◦ Full-Year Revenues from In-Line Products and New Product Portfolio were $35.4 Billion, an Increase of 9%, or 13% When Adjusted for Foreign Exchange • Posts Fourth Quarter GAAP EPS of $0.95 and Non-GAAP EPS of $1.82; Includes Net Impact of ($0.01) Per Share for GAAP and Non-GAAP EPS Due to Acquired IPRD Charges and Licensing Income
  evidence_url: https://www.sec.gov/Archives/edgar/data/14272/000001427223000018/0000014272-23-000018-index.htm
- Earnings Releases
  BRISTOL MYERS SQUIBB CO updated its 2023 guidance (initiated).
  - Period: 2023
  - Guidance: initiated
  - Result: guidance update
  source text: • Provides GAAP and Non-GAAP Financial Guidance for 2023 Reflecting Continued Revenue and Earnings Growth
  evidence_url: https://www.sec.gov/Archives/edgar/data/14272/000001427223000018/0000014272-23-000018-index.htm
- Earnings Releases
  BRISTOL MYERS SQUIBB CO reported full year of 2022 results: revenue $46.2 Billion, EPS $2.95.
  - Period: full year of 2022
  - Revenue: $46.2 Billion
  - EPS: $2.95
  - Result: reported results
  source text: • Reports Fourth Quarter Revenues of $11.4 Billion; Full-Year Revenues of $46.2 Billion ◦ Fourth Quarter Revenues from In-Line Products and New Product Portfolio were $9.0 Billion, an Increase of 7%, or 12% When Adjusted for Foreign Exchange ◦ Full-Year Revenues from In-Line Products and New Product Portfolio were $35.4 Billion, an Increase of 9%, or 13% When Adjusted for Foreign Exchange • Posts Fourth Quarter GAAP EPS of $0.95 and Non-GAAP EPS of $1.82; Includes Net Impact of ($0.01) Per Share for GAAP and Non-GAAP EPS Due to Acquired IPRD Charges and Licensing Income • Reports Full-Year GAAP EPS of $2.95 and Non-GAAP EPS of $7.70; Includes Net Impact of ($0.24) Per Share for GAAP and Non-GAAP EPS Due to Acquired IPRD Charges and Licensing Income
  evidence_url: https://www.sec.gov/Archives/edgar/data/14272/000001427223000018/0000014272-23-000018-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.